TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?
top#TransMedics

TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?

Director David Weill purchased 1,336 shares of TransMedics Group on September 11, 2026. The transaction was disclosed in a regulatory filing and carried a weighted average price of 81 dollars and 63 cents per share.